A Drug Utilization Study To Assess The Usage Of The Fixed-Dose Combination (FDC) Of Teneligliptin + Dapagliflozin In Indian Patients With Type2 Diabetes Mellitus (T2DM) At Various Clinics Across India

Current Trends in Internal Medicine 2026 Open access

Read full text
Authors: Vijay Neglur, Narasimman VKR, Chavi Agarwal, Shivarama Krishna, Aditya Verma, Sumit Bhushan, SANJAY Y. CHOUDHARI, Rahee Borulkar, Kiransing Pawar, Saiprasad Patil
DOI: 10.29011/2638-003x.100252
Cited by: 0

Abstract

By Sumit Bhushan · 2026 · Read by 78 — A Drug Utilization Study To Assess The Usage Of The Fixed-Dose Combination (FDC) Of Teneligliptin + Dapagliflozin In Indian Patients With Type2 Diabetes Mellitus (T2DM) At Various Clinics Across India in Current Trends in Internal Medicine

Fields of Study & Subjects

Diabetes Treatment and Management Diabetes Management and Research Pharmaceutical Practices and Patient Outcomes

Publication details

Journal / source
Current Trends in Internal Medicine
Volume
10
Issue
1
Publication date
12 March 2026
Language
EN